nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale
|
Rao, Meena P. |
|
2016 |
176 |
C |
p. 107-113 7 p. |
artikel |
2 |
Asymmetric dimethylarginine, related arginine derivatives, and incident atrial fibrillation
|
Schnabel, Renate B. |
|
2016 |
176 |
C |
p. 100-106 7 p. |
artikel |
3 |
Cardiovascular health among diverse Hispanics/Latinos: Hispanic Community Health Study/Study of Latinos (HCHS/SOL) results
|
González, Hector M. |
|
2016 |
176 |
C |
p. 134-144 11 p. |
artikel |
4 |
Editorial Board
|
|
|
2016 |
176 |
C |
p. A4- 1 p. |
artikel |
5 |
Extended duration dual antiplatelet therapy in patients with myocardial infarction: A study-level meta-analysis of controlled randomized trials
|
Patti, Giuseppe |
|
2016 |
176 |
C |
p. 36-43 8 p. |
artikel |
6 |
Higher mortality among males in takotsubo cardiomyopathy
|
Pant, Sadip |
|
2016 |
176 |
C |
p. e1- 1 p. |
artikel |
7 |
Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation
|
Eckman, Mark H. |
|
2016 |
176 |
C |
p. 17-27 11 p. |
artikel |
8 |
Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV)
|
Puri, Rishi |
|
2016 |
176 |
C |
p. 83-92 10 p. |
artikel |
9 |
Information for Readers
|
|
|
2016 |
176 |
C |
p. A5- 1 p. |
artikel |
10 |
Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry report
|
Grimfjärd, Per |
|
2016 |
176 |
C |
p. 78-82 5 p. |
artikel |
11 |
Percutaneous coronary intervention for older adults who present with syncope and coronary artery disease? Insights from the National Cardiovascular Data Registry
|
Anderson, Lindsay L. |
|
2016 |
176 |
C |
p. 1-9 9 p. |
artikel |
12 |
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy
|
|
|
2016 |
176 |
C |
p. 63-69 7 p. |
artikel |
13 |
Racial and ethnic differences in atrial fibrillation risk factors and predictors in women: Findings from the Women's Health Initiative
|
Rodriguez, Fatima |
|
2016 |
176 |
C |
p. 70-77 8 p. |
artikel |
14 |
Rationale and design of the First Brazilian Cardiovascular Registry of Atrial Fibrillation: The RECALL study
|
Lopes, Renato D. |
|
2016 |
176 |
C |
p. 10-16 7 p. |
artikel |
15 |
Rebuttal of critique of Progetto Vita survival data
|
Capucci, Alessandro |
|
2016 |
176 |
C |
p. e7- 1 p. |
artikel |
16 |
Response to “Higher mortality among males in takotsubo cardiomyopathy”
|
Khera, Rohan |
|
2016 |
176 |
C |
p. e3- 1 p. |
artikel |
17 |
Shock complicating type A acute aortic dissection: Clinical correlates, management, and outcomes
|
Bossone, Eduardo |
|
2016 |
176 |
C |
p. 93-99 7 p. |
artikel |
18 |
Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial
|
van der Heijden, Liefke C. |
|
2016 |
176 |
C |
p. 28-35 8 p. |
artikel |
19 |
Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations
|
De Luca, Leonardo |
|
2016 |
176 |
C |
p. 44-52 9 p. |
artikel |
20 |
Table of Contents
|
|
|
2016 |
176 |
C |
p. A1-A3 nvt p. |
artikel |
21 |
Tackling cardiovascular disease in Hispanic/Latinos: Achieving 2020 Goals
|
Ventura, Hector O. |
|
2016 |
176 |
C |
p. 125-126 2 p. |
artikel |
22 |
Temporal trends of single-photon emission computed tomography myocardial perfusion imaging in patients without prior coronary artery disease: A 22-year experience at a tertiary academic medical center
|
Jouni, Hayan |
|
2016 |
176 |
C |
p. 127-133 7 p. |
artikel |
23 |
The nonsense paradigm of rethinking the second link of the chain of survival: “if shock is not advised, wait and do nothing!” Aren’t we condemning our cardiac arrest patients?
|
Ristagno, Giuseppe |
|
2016 |
176 |
C |
p. e5-e6 nvt p. |
artikel |
24 |
The on- and off-target effects of morphine in acute coronary syndrome: A narrative review
|
McCarthy, Cian P. |
|
2016 |
176 |
C |
p. 114-121 8 p. |
artikel |
25 |
The “rise of the rule out”: The SPECTer of cardiac stress imaging
|
Lehman, Elmer Philip |
|
2016 |
176 |
C |
p. 122-124 3 p. |
artikel |
26 |
Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trial
|
Blumenthal, James A. |
|
2016 |
176 |
C |
p. 53-62 10 p. |
artikel |